Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Experimental validation of Geant4 nuclear interaction models in dose calculations of therapeutic carbon ion beams

  • Yihan Jia
  • , Martina Favaretto
  • , Lisa Hartl
  • , Markus Stock
  • , Dietmar Georg
  • , Loïc Grevillot
  • , Andreas F Resch

Publikation: Beitrag in Fachzeitschrift (peer-reviewed)Artikel in Fachzeitschrift

Abstract

Background: The choice of nuclear interaction models in Monte Carlo simulations affects the dose calculation accuracy for light ion beam therapy. Purpose: This study aimed to evaluate the dose calculation accuracy and simulation time of three GATE-RTiON/Geant4 physics lists for therapeutic carbon ion beams, assessing their suitability for independent dose calculation in patient-specific quality assurance (PSQA). Methods: The normalized beam models for physics lists QGSP_BIC_HP_EMZ, QGSP_INCLXX_HP_EMZ, and Shielding_EMZ were validated against measurements regarding the accuracy of range, spot size and reference dose. Normalized transversal dose profiles ((Formula presented.)) and field size factor (FSF) were compared with measurements. The accuracy of simulated target dose in 103 fields (various energies, field sizes, depths, and dose gradient (Formula presented.) complexity) of energy-modulated scanned beams was evaluated at 3181 positions. The median of global dose difference (Formula presented.) was calculated at different depth ranges. Results: The three physics lists with validated beam models showed similar accuracy in (Formula presented.) and FSF in the Bragg peak region and proximal depths, while QGSP_INCLXX_HP agreed most closely for (Formula presented.) in the fragmentation tail. Accounting for (Formula presented.) -related uncertainty, (Formula presented.) remained within ±1.1% for QGSP_INCLXX_HP, while exhibiting an overall increasing trend with depth for QGSP_BIC_HP (up to 2.3%) and a decreasing trend for Shielding (down to −4.1%), respectively. By tuning the number-of-primaries/monitor unit conversion ((Formula presented.)) as a function of energy, (Formula presented.) of QGSP_BIC_HP was reduced to within ±1.3%, at the cost of reduced accuracy in the simulated reference dose. The simulation time of Shielding was 1.8 times that of QGSP_BIC_HP and 1.5 times that of QGSP_INCLXX_HP. Conclusions: QGSP_INCLXX_HP demonstrated high dosimetric accuracy in the target region of energy-modulated fields. QGSP_BIC_HP and Shielding showed physics model-related inaccuracies in simulated target dose. Additional (Formula presented.) tuning improved their target dose calculation accuracy with a trade-off of reference dose accuracy. The computationally efficient QGSP_INCLXX_HP and QGSP_BIC_HP are viable candidates for dose calculation applications of carbon ion beam therapy, such as in silico PSQA.

OriginalspracheEnglisch
Aufsatznummere17906
FachzeitschriftMedical Physics
Jahrgang52
Ausgabenummer7
Frühes Online-Datum29 Mai 2025
DOIs
PublikationsstatusVeröffentlicht - Juli 2025

ASJC Scopus Sachgebiete

  • Biophysik
  • Radiologie, Nuklearmedizin und Bildgebung

Fingerprint

Untersuchen Sie die Forschungsthemen von „Experimental validation of Geant4 nuclear interaction models in dose calculations of therapeutic carbon ion beams“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren